Announcements

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

28 February 2024
Meet Us at the British Society for Parasitology Spring Meeting 2024, 2–5 April 2024, Liverpool, UK


Conference: BSP Spring Meeting 2024

Organization: British Society for Parasitology (BSP)

Date: 2–5 April 2024

Place: Liverpool, UK

MDPI journals will be attending the BSP Spring Meeting 2024 as an exhibitor. This meeting will be held in Liverpool, UK, from 2 to 5 April 2024.

The BSP is a not-for-profit, educational charity dedicated to advancing the study of parasitology. The BSP Spring Meeting 2024 is the principal conference for the BSP, attracting around 500 delegates each year from the UK and overseas, covering all aspects of parasitology including diagnostics, disease modeling, molecular biology and vaccines.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following link: https://www.myeventflo.com/event.aspx?m=4&evID=2520.

6 February 2024
Meet Us at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024), 27–30 April 2024, Barcelona, Spain


MDPI will attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) as an exhibitor. This conference will be held in Barcelona, Spain, from 27 to 30 April 2024.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.eccmid.org/.

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

24 January 2024
Acknowledgment of the Reviewers of Pathogens in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Pathogens. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Pathogens received 4642 review reports, from 3730 reviewers. This past year, we worked with reviewers from 94 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Pathogens family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Abdul Kader Jailani Kangkang Chen
Abdul Gafur Karan Varshney
Abel Villa-Mancera Karel Petrzik
Abhik Sen Karen Bohmwald
Abhilasha Kandahalli Venkataranga Nayaka Karen Kyuregyan
Abiola Adepoju Karl Pedersen
Abolfazl Narmani Karla Bitencourth
Abraham Pouliakis Karsten Becker
Adam Kawalek Kashaf Junaid
Adel Girgis Kateryna Davydenko
Adhikarimayum Lakhikumar Sharma Katharine Carter
Adilson Bauhofer Kathleen Burek-Huntington
Adina Marza Katsunori Okazaki
Adli Ali Kazumoto Murata
Adrían Rodríguez-Carlos Kazuya Morimatsu
Adriana Anita Kelly Harrison
Adriana Erica Miele Keni Vidilaseris
Adriana Patricia Corredor-Figueroa Kenneth Liegner
Adriana Silva-Iturriza Kentaro Kato
Agustin Ariño Kevin Temeyer
Ahmed Elbestawy Kgaugelo Lekota
Ahmed Elgazzar Khairul Syahputra
Ahsanullah Unar Khalid Masoodi
Aimee Eggler Kharleezelle J. Moendeg
Aitor Garcia-Vozmediano Kin Kui Lai
Aivars Berzins Kishore Vaddadi
Ajay Akhade Konrad Sachse
Akebe Luther King Abia Konstantinos Arsenopoulos
Akram Da'darah Krzysztof Tomczuk
Akshaya Bhagavathula Kuldeep Gupta
Alan J. Weaver, Jr. Kun-Hsien Tsai
Alda Natale Kunihiko Umekita
Alejandro Escamilla Sánchez Kursat Altay
Alessandra Barlaam Labrini V. Athanasiou
Alessandra Sinopoli Lakha Salaipeth
Alessio Sposato Lance Keller
Alexander Kirillov Larry Wolfraim
Alexandra Ibáñez-Escribano Laurent Bigarré
Alexey Rakov Laurent Roberto Chiarelli
Alexis Ribas Salvador Lauro Velazquez-Salinas
Alfonso Aguilar-Perera Leandro Buffoni Perazzo
Ali Adem Bahar Lee Nguyen
Ali Rezaei-Matehkolaei Leonard Koolman
Alica Kočišová Leonardo Martín Pérez
Alice Chiara Manetti Leslie Adams
Alice Michelutti Leszek Tylicki
Alice Monzani Lia Van der Hoek
Alice Zwerling Long Pham
Alicia Ponte-Sucre Longding Liu
Alisa Mikhaylina Loredana Sigillo
Amjad Abu Hasna Lorenzo Domenis
Amol Pohane Lorenzo Onorato
Amy Pickering Lorina Badger-Emeka
Ana Belen Blazquez Martin Lourdes Mateos Hernández
Ana Camila Micheletti Lubomira Nikolaeva-Glomb
Ana Cláudia Coelho Luca Scapoli
Ana Domingos Luca Stucchi
Ana Huertas López Lucas Magalhães
Ana Isabel Pinto Luciana-Catalina Panait
Ana Leticia Fornari Caprara Lucinda Bessa
Ana Paula Arez Luis Anibarro
Ana Silva Luis Collado
Ana Vasić Luis Larrea
Anamaria Ioana Paştiu Luis Parizi
Ananda Ayyappan Jaguva Vasudevan Luis Sánchez Vargas
Anastasia Diakou Luisa Jordao
Anastasia Spiliopoulou Łukasz Depa
Andi Krumbholz Lukasz Kedzierski
André Aires Luzia Helena Queiroz
André Luis Costa-Da-Silva Lyda Raquel Castro
André Luis Santos Lysandro Pinto Borges
André Pereira Lyudmila Kokaeva
Andrea Bardůnek Valigurová Maciej Frant
Andrea Bilger Madalina Preda
Andrea Karin Thoma-Kress Magda Bletsa
Andrea Sanso Mahmoud Fayez
Andrei Vata Mahmoud Hammad
Andreia Brilhante Mahmoud Kandeel
Andrés Uc-Cachón Mahmoud Singer
Andrew Freedman Mahmoud Tabrizi
Andrew Jenkins Mahmoud Tawfick
Andrey Sgibnev Majed Wakid
Aneta Bełcik Majid Komijani
Aneta Klotzka Małgorzata Dmitryjuk
Angela Pearson Małgorzata Juszkiewicz
Angelika K. Loots Malin Lager
Angelo Romano Mamohale Chaisi
Angus Oli Mangesh Yuwaraj Dudhe
Anil Kumar Vijjamarri Manish Dhawan
Anisuzzaman Anisuzzaman Manoel Oliveira
Ankit Shroff Manoj K. Sekhwal
Ankur Bothra Manoj Kumar
Anna Luganini Manu Anantpadma
Anna Majewska Manuel Anguita Maeso
Anna Palko-Labuz Manuel Rodriguez-Iglesias
Anna Rosa Garbuglia Marc Herb
Anna Rzasa Marc Vasse
Anna Szczerba-Turek Marcela Lareschi
Anna Szczotka-Bochniarz Marcela Lizano
Anna Timofeeva Marco Alexandre Guerreiro
Annalisa Chianese Marco Cosentino
Annie Frelet-barrand Marco Dolci
Antonia Lock Marco Verani
Antonieta Guerrero-Plata Marcos André
Antonino Catara Marcos Godoy
António Machado Marcos Toledo
Antonio Minervino Marek Asman
Antonio Ortega-Pacheco Maria Angelica Guimarães
Anupam Mukherjee Maria Aragona
Anurag Shukla María Buendía-Abad
Apichat Vitta Maria Calado
Aravinthkumar Jayabalan Maria Cristina Schneider
Arianna Calistri María del Carmen Muñoz Egea
Aris Kaltsas María del Rocío Reyes-Montes
Arlei Coldebella Maria Fortofoiu
Arlind Mara María Guadalupe Frías-De-León
Arno Swart María Jesús Serrano Andrés
Arnold Rabson Maria José Borrego
Arnoldas Pautienius Maria Leonor Faleiro
Ashaimaa moussa María Pisano
Ashish Pandey Maria Salome Gomes
Ashley Cluck Maria Teresa Manfredi
Ashokkumar Manickam Mariagrazia Perilli
Ashutosh Dubey Marianna Domán
Athanasia Varsaki Marianna Martinelli
Atul Agrawal Mariarosaria Campise
Aurelijus Burokas Marina Mat Baki
Aurelio Ciancio Marina Sofia
Awadalkareem Adam Marino Paroli
Ayixon Sánchez-Reyes Mario Cruciani
Babak Pakbin Mario Pérez-Sayáns
Baba-Moussa Lamine Marion Ferren
Baji Shaik Màrius V. Fuentes
Balasubramaniam Boopathi Mariusz Dyląg
Balint Gergely Szabo Mark Musch
Bambang Sugiharto Mark Wiser
Barbara Brunetti Marko Pajić
Barbara Moroni Markus Keller
Barry Palmer Marta Canuti
Basem Battah Marta Pawłowska
Bassam Elgamoudi Martin Richter
Beata Wodecka Marwan Osman
Beatrice Paradiso Mary Maj
Benjamin Lee Masahiro Yasuda
Benti Gelalcha Masayoshi Yada
Bernardo Vega Crespo Massimo Spedicato
Bernhard Krismer Matheus Cruz
Beth Garvy Matias Castells
Bharadwaja Srimat Tirumala Peddinti Matias Perez
Biagio Santella Matthew Painschab
Bindu Subhadra Matthew Scott
Binod Sahu Mattia Dominoni
Biruta Bankina Mattia Mori
Biswa Maharana Mauro Giacomelli
Bo Zhou Mauro Martínez
Bobo Mok Maxim Khasnatinov
Boniface Pone Kamdem Mayo Yasugi
Boyko Georgiev Mazen Almehmadi
Bradley Groveman Md. Abdus Sobur
Branko Velebit Md. Saiful Islam
Brian Crook Mebrahtu Tedla
Bruno Arcà Mehdi Nateghpour
Çağrı Ergin Melanie Rissmann
Calin Mircea Gherman Melinda Herbath
Cao-An Vu Meng-Jia Lau
Carla Fontana Mengmeng Zhao
Carla Miranda Merveille Koissi Savi
Carla Novais Michael Harding
Carla Pagliari Michael Maniaci
Carla Viegas Michael Minnick
Carlos Almeida Michael Rahe
Carlos Caro Salazar Michela Bertola
Carlos Gaspar Michiel Wijnveld
Carlos Martín Ardila Miguel Peixoto de Almeida
Carmen Pavelescu Miguel Rubio-Godoy
Carmine Izzo Miguel Sanchez-Aleman
Carolina Davies Mihaela Ileana Ionescu
Carolina Hernández Lara Mihaela Luca
Carolina Pacca Mihaela Niculae
Caroline Frey Mikel Vicente-Pascual
Cassandra Olds Minakshi Rana
Cassidy Rist Minghang Wang
Catalina Avendaño Mirela Petrić
Catalina Rey-Valeirón Mithil Soni
Catherine Jia-Yun Tsai Modra Murovska
Cátia Ramalhete Mohamed Al-Agamy
Cecilia Ximenez Mohamed Fawzy
Cesar Roque-Borda Mohamed Hassan
Chada Norphanphoun Mohamed Lounis
Chandra Mishra Mohamed Orabi
Chang Huang Mohamed Rahouma
Changjun Huang Mohamed Rizk
Chao Wang Mohamed Shaalan
Chaoqun Yao Mohammad Aatif
Charles Foster Mohammad Ali Al-Deeb
Chen-Hua Liu Mohammad Arabestani
Chiara Pinoni Mohammad Arif Rahman
Chienhsiu Huang Mohammad Yousef Memar
Chinmay Surve Mohammad Zamani
Chinmay Vijay Tikhe Mohammed Rohaim
Chinnaperumal Kamaraj Mohd Saqib
Choosak Nithikathkul Mohsin Khurshid
Christian Barbato Mona El-Zamkan
Christian Menge Mona I. Shaaban
Christiane Schnee Monalisa Sahoo
Christine Unterweger Mónica Acevedo
Christophe Escudé Monica Santin
Christos Stefanis Mónica Vieira
Chun-Song Yang Monika Olech
Ciro Romano Monika Rinder
Clara Lima Morgan Brisse
Clariss Blanco Muhammad Junaid Dar
Claude Charvet Muhammad Imran Rashid
Claudia Dick Muhammad Mahmood
Clemax Couto Sant’Anna Muhammad Mohsin
Corneliu Ovidiu Vrancianu Muhammad Nauman Zahid
Cory Robinson Muhammad Nawaz
Cristian Alexandru Magdaş Muhammad Yasir
Cristiane Lamas Muhammed duman
Cristiano Salata Munho Ryu
Cristina Galvan Münir Aktaş
Cristina Nastasă Musharaf Ahmad
Cuma Mertoglu Mustafa Sevindik
Dagmara Złotkowska Muthu Sankar
Dalia Raïch-Regué Nadeem Ullah
Dan-Alexandru Toc Nadezhda Fursova
Danica Bogunović Nadia Ali
Daniel Friedman Nadine Krüger
Daniel Hernandez-Patlan Namdev Togre
Daniel Kwakye Nomah Nancy Edith Lozoya-Pérez
Daniel Młocicki Nancy Weiland-Bräuer
Daniel Noyola Natalia Kreshchenko
Daniel Scott Natalia Lomakina
Danielly Corrêa-Moreira Natalia Statsyuk
Danijela Černe Nazmul Islam
Danijela Miljanovic Nebojsa Ilic
Daria Eroshenko Neetika Jaisinghani
Daria Lebedeva Nicolai S. Panikov
Daša Stupica Nicolás Galarce
David Emanuel Reyes-Guerrero Nicolas Kieffer
David R. Allred Nicolas Ruggli
David R. McGivern Nicolò Brandi
David Scheim Nidia Arechiga-Ceballos
Dawei Zhou Nighat Perveen
Deemah Dabbagh Nikhat Parveen
Delphine Le Roux Nilakshi Barua
Denis Lagutkin Nilanjan Lodh
Derek Toms Nilima Rajpal Kundnani
Desire Casares Marfil Niroshan Thanthrige-Don
Dianbao Zhang Nitin Amdare
Dianjun Cao Nityanand Jain
Dick Lindhout Nkululeko Nyangiwe
Diego Francisco Faccone Norma Santos
Dimitrina Miteva Norzawani Jaffar
Dimitris Tsakogiannis Noula Shembade
Dina Coertzen Noura M. Seleem
Dinesh Mittal Oleh Andrukhov
Ding Wang Oleksii Skorokhod
Dirceu Ramos Olga A. Glazunova
Djamal Brahim Belhaouari Olga Andrievskaia
Dominik Łagowski Olga Lilia Garibay-Cerdenares
Donato Raele Olga Matveeva
Dong Keon Yon Olga Vadimovna Kurmyshkina
Dorota Tichaczek-Goska Olgica Stefanovic
Durgesh Jaiswal Olivier Escaffre
Duygu Sari-Ak Oluwatoyin Adeleke
Ebubekir Yüksel Onur Ceylan
Edoardo Carretto Orsolya Dobay
Edson da Silva Oscar Vargas-Rodriguez
Eduardo Alvarez Duarte Osman Aktaş
Eduardo José Lopes-Torres Oswaldo Palenzuela
Eduardo Montoya-Diaz Panagiotis Karanis
Edward Murphy Pasquale Saldarelli
Edward Walker Pasquale Santoro
Ehsan Ahmadpour Patricia Barroso Seano
Eileen Roulis Patricio Retamal
Elena Carra Patrick Arbuthnot
Elena Dantes Pau Bosch-Nicolau
Elena Shipitsyna Paul Arnaboldi
Eleni Katsogiannou Paul Higgins
Elham Kazemirad Paul Kupke
Eliana De Gregorio Paulina Podgoreanu
Elisabeth Liebler-Tenorio Paulina Przyborowska-Zhalniarovich
Elliot Androphy Paulo Carmo
Eloiza May Galon Paweł Krzyżek
Elpidius Rukambile Pawel Zmora
Elsayed Mehana Payam Behzadi
Elżbieta Łopieńska-Biernat Pedro Amado Cecilio
Emad Ata Pedro Ferreira
Eman Khalifa Per Jensen
Emanuele Pontali Perveen Summia
Emanuelle Farias Petr Pyszko
Emily Ledgerwood  Petr Zeman
Emmanouil Magiorkinis Petra Bandelj
Emmanuel Okechukwu Njoga Phil T. LoVerde
Ener Dinleyici Philip Serwer
Enrique Reyes-Novelo Phirom Prompiram
Eric Niesor Phuong Thi Hoang
Érica Martins-Duarte Piera Anna Martino
Erika Guimaraes Piyush Baindara
Erin van Schaik Prabhat Singh
Esperanza Duarte-Escalante Pradeep Uchil
Esperanza Gomez-Lucia Pradeep V. Kadambi
Eva Torres-Sangiao Prakash Ghosh
Evgen Multia Priscila Moraes
Evgeny Ermakov Priyanka Sharma
Ewa Tomaszewska Przemyslaw Cwynar
Ewa Wiesik-Szewczyk Qi Miao
Ewen Todd Qi Song
Ezequiel Fuentes-Pananá Qibin Geng
Fabio Fiorino Qingli Dong
Fabio Possebon Qudrat Ullah
Fabrice Compain Rachid Sabbahi
Fabrizio Angius Rachy Abraham
Fanfan Zhang Radha Gopalaswamy
Farina Mustaffa Kamal Radu Crișan-Dabija
Fátima Amaro Radu Miftode
Fatma Eldemery Rafael Leva
Fausto Fiori Rafael Rivera-Bustamante
Federica Fogacci Rafael Zaragoza
Federico Armando Rafaella Ioshino
Federico Pratesi Rafał Watrowski
Feiying Zhu Ragab Fereig
Felipe Bonfim Freitas Rajendra Upadhya
Felipe Masiero Salvarani Raktham Mektrirat
Felipe Santiago-Tirado Ramendra Pandey
Ferenc Orosz Ramesh Das
Fernanda Fonseca Raphael B. Stricker
Fernanda Morgado Raquel Cossio-Bayugar
Fernando Cardoso Raúl Alegría-Morán
Fernando Ferreira Razeghian-Jahromi Iman
Fernando Guerra-Infante Razvan-Cosmin Petca
Fernando Jacinavicius Rebecca Tallmadge
Fernando Monroy Renata Neves
Filip Boyen Renata Pereira
Fiore Alfonsina Renata Pimentel Bandeira de Melo
Flávio Lara Rene Kaden
Flor Helene Pujol Rene Olsthoorn
Florian Schulz Renu Wickremasinghe
Francesco Mira Reza Shirazi
Francisco Campello do Amaral Mello Ricardo Pérez-Sánchez
Francisco de Asís Bartol-Puyal Riccardo Moretti
Francisco Ferreira Richard Stanton
Francisco Les Rijkelt Beumer
Francisco Pilar-Orive Rita De Sanctis
Franco Mutinelli Rita Teixeira-Santos
Franjo Martinković Ritthideach Yorsaeng
Franz Conraths Robert Ancuceanu
Franz-Georg Hanisch Robert Bransfield
Frédérique Pasquali Robert Harrod
Fuguo Xing Robert James Walker
Gabriel Augusto Marques Rossi Robert Stryiński
Gabriel López-Velázquez Robert Suslo
Gabriel Parra Roberta Koku
Gabriela Goujgoulova Roberto Cortinas
Gabriela Mellado-Sanchez Roberto Zenteno-Cuevas
Gabriela Motoie Rodolfo Lagunes-Quintanilla
Gabriele Pagani Rodrigo Morchón
Gabriella Gaglio Rodrigo Nunes Rodrigues-da-Silva
Gagandeep Saggu Rogelio de J. Treviño-Rangel
Galia Ramírez-Toloza Roger Chong
Galina Shepelkova Roger Dumke
Gamal Wareth Rogério Laurentino
Ganesh Ram Visweswaran Rolf Schuster
Gang Ye Romain Veyron-Churlet
Gaurav Joshi Romana Moutelíková
Gaurav Kumar Romeo-Teodor Cristina
Gemma Jiménez Guerra Rosa Di Crescenzo
George Broukhanski Rosa Elena Cardoza
George Deepe Rosario Nicoletti
George Michail Rosilainy Fernandes
George Valiakos Ross Larue
Georges Snounou Rossana Arroyo
Georgi Beev Roxana Maria Nemeș 
Georgia Kalodimou Rubén L. Rodríguez-Expósito
Georgiana Deak Ruining Wang
Georgiana-Emmanuela Gilca-Blanariu Rumyana Markovska
Georgios Tampakoudis Runhui Zhang
Gerardo Santos-Lopez Ruojun Wang
Gerardo Vázquez-Marrufo Sabir Hussain
Gergana Zahmanova Safa Oufensou
German Gornalusse Saikat Paul
Gert Venter Sakshi Arora
Ghassan Ghssein Sami Simsek
Gianluca Rugna Sandeep Chaudhary
Gina Harper Sandrama Nadan
Giorgio Gallinella Sa-nga Pattanakitsakul
Giovanni Corrado Santhosh Kumar Rajamani
Giovanni Franzo Santi Mandal
Giovanni Milanez Santiago Mirazo
Giuseppe Bruno Santo Previti
Giuseppe Valerio De Gaetano Santosh Dhakal
Gopinath Prakasam Santosh George
Göte Swedberg Sara Primavilla
Goutam Banerjee Sara Savić
Graham Burgess Sarah Jiang
Graham Taylor Sari Mohali-Castillo
Grazia Pavia Satyabrata Nanda
Guang Xu Saumya Anang
Guido Pietroluongo Saumya Shah
Guilherme Campos Sean Whittier
Guilherme Zagui Sebastián Martínez Kopp
Gulce Sari Sébastien Lhomme
Gurjeet Kaur Selvakumar Subbian
Gustavo Rodrigues Makert dos Santos Seonghyang Sohn
Hafiz Muhammad Rizwan Serena Cavallero
Haidi Ramadan Sergei Grishin
Hang Su Sergei Nikolaevich Shchelkunov
Hanna Harant Sergei Raev
Harun Albayrak Sergei Sokolov
Hasan Ejaz Sergio Gastón Caspe
Hazem Ramadan Sergio Schenkman
Heather Burrow Serhat Sirekbasan
Heba Zaghloul Seung-Hun Lee
Héctor Mora-Montes Severo Vázquez Prieto
Heliana Dundarova Shakir Khan
Helio Langoni Sharilyn Almodovar
Helle Bielefeldt-Ohmann Shawky Aboelhadid
Hend Abdullah Shekhar Saha
Heng-Chang Chen Sheng-Qun Deng
Henk Schallig Shi Lei
Heriberto Fernandez Shin-ichi Ito
Hesamaddin Shirzad-Aski Shin-nosuke Takeshima
Hesham Moustafa Shitou Xia
Himadri Biswas Shruthi Mohan
Hin Chu Shuai Wang
Hira L. Nakhasi Shuhei Yoshida
Hirofumi Akari Sicun Fan
Hiroshi Yoneyama Siham Fellahi
Ho-Joon Shin Silvia Bonetta
Honghua Hu Silvia Ravagnan
Howard Takiff Silvina Fernandez
Hubert Marotte Simon Peter Musinguzi
Hugo Ramírez Álvarez Simona Sagona
Hugo Vilhena Simonetta D'Ercole
Huiqiang Wang Singh Avishek
Huixing Lin Sinh Dang
Hülya Şimşek Sk Mohiuddin Choudhury
Hung King Tiong Slaven Jozić
Hussein Hamade Sofia Costa-de-Oliveira
Huyen Do Sonam Shakya
Hye Ryoung Kim Song Yu
Hyun-Woo Park Sonia Moretti
Ian Hodgson Sonia Zúñiga
Ibrahim Abbas Sotirios Kalfas
Ibrahim Sayed Souleymane Doucoure
Igor Andrade Santos Srinivas Nellimarla
Igor Oscorbin Srinivas Sura
Ilaria D'Agostino Stamatoula Tsikrika
Ilaria Pascucci Stefania Perrucci
Ildefonso Fernández-Salas Stefano Fornasaro
Ileana Adela Vacaroiu Steffen Rupp
Ilkka Julkunen Stephen Morris
Imaan Benmerzouga Steven Zink
Imbi Nurmoja Stoyanka Stoitsova
Indrė Lipatova Sujeet Kumar
Inge Kroidl Suman Lata Wattal
Inge Larsen Sunghyun Yoon
Ioanna Alexandropoulou Surajit Basak
Ioannis Giantsis Susan Cohen
Ioannis Ventoulis Susana Sousa
Iolanda Moretta Susanna Sternberg-Lewerin
Ionela-Larisa Miftode Sutherland K. Maciver
Ira Jain Suvi Taponen
Irena Tabain Suzanne Koptur
Irena Wojsyk – Banaszak Sveinung Sorbye
Irina Le-Deygen Sven Pischke
Isabel Mauricio Svetlana Ermolaeva
Isabella Faraoni Svetlana Rachina
Isabelle Florent Swastik Phulera
Isaia Symeonidou Syazwan Saidin
Isidora Vujcic Syazwani Itri Amran
Ismail Odetokun Sylvie Lecollinet
Itzel López-Rosas Taís Fukuta Cruz
Itziar Chapartegui-González Takafumi Tsuboi
Ivan Sabol Takashi Kumagai
Ivana Šimić Tanel Punga
Ivar Tjernberg Taner Sar
Ivo Alexandre Leme da Cunha Tanja Pessi
Jack Leo Tanya Strateva
Jacquelina Woods Tao Wang
Jacques Cabaret Tara Chand Yadav
Jader de Oliveira Tarun Keswani
Jaggi Ujjaldeep Tatjana Vilibic-Cavlek
Jaime Bustos-Martinez Tatsunori Nakano
James Bogan Taweegrit Siripongboonsitti
Jamille Dombrowski Tengguo Li
Jana Held Terenzio Cosio
Janet Nale Teresa Letra Mateus
Janja Trček Teresa Lettini
Janusz Madaj Teresa Vinuesa
Jarl Bøgwald Tesfaye Gelanew
Jarosław Walory Teshome Yehualaeshet
Jasmin Hufschmid ThankGod Onyiche
Jason Cantera Thomas Svoboda
Javier Carrión Thorsten Kuczius
Javier Ventura-Juárez Timothy R. Hoover
Jayeshbhai Chaudhari Ting Zhang
Jean Luc Murk Ting-Yu Cheng
Jean Vanderpas Tingyu Duan
Jean-françois Magnaval Tomasz M. Karpinski
Jean-Pierre Kabue Tomislav Šarić
JebaMercy Gnanasekaran Torben Sølbeck Rasmussen
Jefferson Vaughan Torsten Seuberlich
Jeffrey Jeff Adamovicz Trevor Williams
Jelena Blagojević Ulises Hernández
Jelena Nesovic Ostojic Uma Gautam
Jelena Prpić Umberto Molini
Jennifer Moffat Usama Ashraf
Jeremy Camp Utthapon Issara
Jeroen Pollet Vahab Farzan
Jesús Hernández Valentina Foglia Manzillo
Jesus Tamariz Valentina Virginia Ebani
Jiafen Hu Valentine Usongo
Jiangong Liang Vangelis Economou
Jianhai Chen Vania Matta
Jianing Chen Vanja Kaliterna
Jianing Fu Vasco Menconi
Jiekai Yin Vasileios P. Papadopoulos
Jigang Yin Vassiliki Pitiriga
Jimmy T. Efird Vassilis Skampardonis
Jing Li Veerle Msimang
Jinhu Xu Velmurugan Balaraman
Jinyan Zhang Venkat Chirasani
Jinyang Zhang Venkateswarlu Kanamarlapudi
Jiong Chen Venkatraman Siddharthan
Jitendra Kumar Tripathi Venkatramana Divana Krishna
Joachim Müller Veronica R. Flores
Joana Sabino Pinto Vesna Milicevic
Joanna Maj-Paluch Victor Dahl
João B. Cota Víctor Manuel Hernández-Velázquez
João Brandão Victor Midlej
Joaquin Quilez Victoria Pando-Robles
Joel Soares Filipe Viliam Šnábel
Johannes Schmidt Vinicus Bello
John Halperin Vitalii Timofeev
Jon P. Woods Vivi Miriagou
Jonathan LeCureux Vladimir Diaz-Ochoa
Jordi Cabrefiga Vladimir Gostev
Jordi Serra-Cobo Vladimir P. Zhdanov
Jorge Cortes Vladimir Yeremeev
Jorge Lago Wael El-Deeb
Jorge Silva Jara Wagner Quintilio
Jorlan Fernandes Walderez Dutra
José A. García-Sanz Waleed Younis
Jose Alejandro Martinez-Ibarra Wanderley De Souza
José C. De La Flor Waqas Ahmad
Jose Cano-Buendia Wattana Pelyuntha
Jose Iannacone Weerachai Saijuntha
José Luis Vázquez-Ibar Wendell Perinotto
Jose M. Mendez-Arriaga Wenjun Zhu
José Manuel Jaramillo Ortiz Wensheng Fang
José Manuel Pérez-Cañadillas William L. Irving
José Matos William Schwan
José Rafael de Almeida Wolf-Rainer Abraham
Jose Reyes Gonzalez-Galaviz Wolfram Gerlich
Josef Harl Xi Huang
Joseph Falkinham Xiaoying Yu
Joseph Michael Oduor Xiaoyong Zhang
Joseph Servadio Ximena Porcasi
Joshua Amimo Xin Liu
Joshua Anzinger Xin Yang (Northwest A&F University)
Jozsef Dudas Xin Yang (South China Agricultural University)
Juan Carlos Caicedo Xinhong Chen
Juan Carlos Espinosa Xudong Fan
Juan Fidel Osuna-Ramos Xueyong Zhang
Juan Hernandez-Garcia Yahya Al Naggar
Juan Luis Muñoz Bellido Yanan Liu
Juan Mantilla Yanjin Zhang
Juandy Jo Yashavanth Shaan Lakshmanappa
Julia Walochnik Yasmine Tartor
Julian Freen-van Heeren Yihong Xiao
Julian Muñoz Yolandy Lemmer
Julián Ruiz-Sáenz Yong-Hong Hu
Julian Shepherd Yu Gu
Julie Fox Yubao Wang
Julio Chacón-Hernández Yun Shi
Julio V. Figueroa-Millán Yunus Beyhan
Jumari Snyman Yuta Hikichi
Junichi Inaba Yutaka Tagaya
Juri Boguniewicz Zakaria Baka
Justin Greenlee Zan Li
Justyna Mazurek-Popczyk Zehui Zhang
Jyoti Das Zhanying Hu
Kadir Akan Zhengwei Huang
Kai Siang Chan Zhenlu Chong
Kai Song Zhijun Yu
Kai Zheng Zhiying Deng
Kaichuang Shi Zorana Dobrijević
Kamenna Vutova Zsolt Toth

2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

29 December 2023
Prof. Dr. Yuying Liang Appointed Section Editor-in-Chief of the Section “Viral Pathogens” in Pathogens

text

We are pleased to announce that Prof. Dr. Yuying Liang has been appointed as the Section Editor-in-Chief of the Section “Viral Pathogens” in Pathogens (ISSN: 2076-0817).

Dr. Yuying Liang is a professor at the Department of Veterinary and Biomedical Sciences at the  University of Minnesota, Twin Cities (USA). She holds a B.Sc from Sichuan University (China), an M.Sc from the Shanghai Institute of Biochemistry, Chinese Academy of Science (CAS) (China), and a Ph.D. from the University of British Columbia (Canada).

 

Dr. Liang's research focuses on understanding the molecular mechanisms of viral replication and pathogenesis, and utilizing this knowledge to develop novel preventative and treatment measures for viral diseases in humans and animals. Her current research projects involve two RNA viral pathogens, Lassa fever virus and influenza virus, the former causing highly virulent hemorrhagic fever disease in humans and the latter remaining a global threat to human and agricultural animal health. Studies from Dr. Liang's laboratory have revealed novel mechanisms by which these viruses interact with host innate immune systems and cell signaling networks to promote viral replication and cause virulent infections in hosts. In addition, they utilize the knowledge and molecular tools of arenaviruses to develop a novel, safe, and effective viral vaccine platform, with which they will develop effective vaccines against various pathogens including diverse arenavirus pathogens and frequently evolving influenza viruses. Finally, Dr. Liang's lab is interested in studying the roles of host factors and signaling pathways in influenza viral replication and disease pathogenesis in the lungs with the ultimate goal of developing novel antiviral therapeutics against influenza viral infection.

The following is a short Q&A with Dr. Yuying Liang, who shared her vision for the journal with us, as well as her views on the research area and open access publishing:

1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?
I have always been impressed by the exceptional level of professionalism and timely assistance provided by the journal’s staff, editorial board, and reviewers.

2. What is your vision for the journal?
I would like to help enhance the breadth of coverage of the pathogens being featured in the Pathogens journal and to help maintain the rapid manuscript processing speed as well as the quality of publications in this journal.

3. What does the future of this field of research look like?
I believe in the One Health research approach that can help fully understand the impact that humans, animals, and the environment have the pathogens. Understanding how these factors can influence the behavior of different pathogens can have a direct and significant impact on the health of humans and animals.

4. What do you think of the development of Open Access in the publishing field?
I believe in the Open Access model of publication that can help level the playing field for all researchers and can make discoveries accessible to all in a timely manner.

We warmly welcome Prof. Dr. Yuying Liang as the Section Editor-in-Chief of the Section “Viral Pathogens”, and we look forward to achieving many milestones under her leadership.

26 December 2023
Pathogens | Section “Prions” Is Discontinued

After discussion with the Editor-in-Chief and consideration of the scope and focus of Pathogens (ISSN: 2076-0817), we have decided to close the Section “Prions”. All published papers and closed Special Issues will remain unchanged. All papers that are currently under processing in this Section will be moved to other Sections or be taken as regular papers of the journal. We still accept articles related to prions as long as they fall within the scope of Pathogens.

Pathogens Editorial Office

30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

Back to TopTop